IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,048,000 | +1050.0% | 47,604 | +379.1% | 0.19% | +905.3% |
| Q2 2020 | $352,000 | +718.6% | 9,936 | +207.9% | 0.02% | +533.3% |
| Q1 2020 | $43,000 | -36.8% | 3,227 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $68,000 | +58.1% | 3,227 | +3.2% | 0.00% | +33.3% |
| Q3 2019 | $43,000 | 0.0% | 3,127 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $43,000 | -28.3% | 3,127 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $60,000 | +33.3% | 3,127 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $45,000 | -30.8% | 3,127 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $65,000 | -11.0% | 3,127 | +1.8% | 0.01% | -16.7% |
| Q2 2018 | $73,000 | +62.2% | 3,072 | 0.0% | 0.01% | +50.0% |
| Q1 2018 | $45,000 | -10.0% | 3,072 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $50,000 | +78.6% | 3,072 | +53.6% | 0.00% | +33.3% |
| Q3 2017 | $28,000 | +55.6% | 2,000 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $18,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |